Suppr超能文献

即时检测与中心实验室检测血细胞比容、血红蛋白和电解质浓度的比较。

Comparison of point-of-care versus central laboratory measurement of hematocrit, hemoglobin, and electrolyte concentrations.

作者信息

Gavala Alexandra, Myrianthefs Pavlos

机构信息

National and Kapodistrian University of Athens, School of Health Sciences, Department of Nursing, "Agioi Anargyroi" General Hospital, Noufaron & Timiou Stavrou, Nea Kifissia, 14564, Athens, Greece.

National and Kapodistrian University of Athens, School of Health Sciences, Department of Nursing, "Agioi Anargyroi" General Hospital, Noufaron & Timiou Stavrou, Nea Kifissia, 14564, Athens, Greece.

出版信息

Heart Lung. 2017 Jul-Aug;46(4):246-250. doi: 10.1016/j.hrtlng.2017.04.003. Epub 2017 May 3.

Abstract

OBJECTIVES

We aimed to investigate the accuracy of certain laboratory examinations obtained by the ABG analyzer (ROCHE AVL OMNI S) as compared to hospital central laboratory (CL).

METHODS

We prospectively collected data obtained from the same arterial blood sample regarding hematocrit, hemoglobin, potassium, and sodium.

RESULTS

ABG analyzer results were significantly lower (p < 0.0001) compared to CL values thus values between the two methods are not interchangeable. The mean bias for Hb, Na and K were within accepted by US Clinical Laboratory Improvement Amendment (USCLIA) differences (cut-off points) but not for Ht. In 8.0%, 17.5%, 37.5% and 56.0% of Hb, Na, K and Ht measurements respectively and 29.75% in sum the differences were over the USCLIA accepted limits. ABG analyzer significantly underestimate the values of Hb, Ht, Na and K, compared to CL and almost 30% of all examined parameters were beyond USCLIA accepted biases.

CONCLUSIONS

ABG analyzer significantly underestimates the values of Hb, Ht, Na and K compared to CL and almost 30% for all examined parameters are beyond USCLIA accepted biases. These data do not support widespread or even careful use of POCT for making diagnostic and treatment decisions until technology improves and results in improved outcomes.

摘要

目的

我们旨在研究与医院中心实验室(CL)相比,ABG分析仪(ROCHE AVL OMNI S)所获得的某些实验室检查结果的准确性。

方法

我们前瞻性地收集了来自同一动脉血样本的血细胞比容、血红蛋白、钾和钠的数据。

结果

与CL值相比,ABG分析仪的结果显著更低(p < 0.0001),因此两种方法的结果不可互换。血红蛋白、钠和钾的平均偏差在美国临床实验室改进修正案(USCLIA)规定的差异(临界点)范围内,但血细胞比容不在此范围内。血红蛋白、钠、钾和血细胞比容测量结果分别有8.0%、17.5%、37.5%和56.0%,总计29.75%的差异超出了USCLIA规定的限值。与CL相比,ABG分析仪显著低估了血红蛋白、血细胞比容、钠和钾的值,并且几乎30%的所有检测参数超出了USCLIA规定的偏差范围。

结论

与CL相比,ABG分析仪显著低估了血红蛋白、血细胞比容、钠和钾的值,并且几乎30%的所有检测参数超出了USCLIA规定的偏差范围。在技术改进并带来更好的结果之前,这些数据不支持广泛甚至谨慎地使用即时检验(POCT)来做出诊断和治疗决策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验